Home Health Care News October 28, 2024
Andrew Donlan

Earlier this month, Walgreens Boots Alliance (Nasdaq: WBA) CEO Tim Wentworth laid the groundwork for a company turnaround. Part of that included a shift away from certain health care services, which the company pivoted toward in the wake of the COVID-19 pandemic.

After that, at the HLTH conference in Las Vegas, Mary Langowski – the president of Walgreens’ U.S. Healthcare segment – dove further into Walgreens’ health care strategy moving forward.

On an earnings call, Wentworth explained that the company would be “reorienting” the business. Part of that reorientation would be closing about 1,200 underperforming Walgreens stores over the next few years.

“WBA is reorienting to its legacy strength as a retail pharmacy-led company,” he said. “This reorientation allows us...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
What might a Trump administration mean for the Biosecure Act?
Q&A: Reducing Mental Health Stigma Starts in Pharmacies
Flagship, Pfizer alliance yields two more startup deals
Payment Disrupters and Opportunities: Key Trends That Impacted Pharmacy in 2024
GeneDx Launches Tool to Fuel Rare Disease Drug Discovery

Share This Article